Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Nicolazzi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Antiviral Research|June 14, 2002
In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strainsCéline Nicolazzi, Véronique Venard, Alain Le Faou, et al.
The Journal of Gene Medicine|February 24, 2004
Physicochemical optimisation of plasmid delivery by cationic lipidsIsabelle Tranchant, Betty Thompson, Céline Nicolazzi, et al.
Current Medicinal Chemistry|April 8, 2003
Cationic lipids for transfectionCéline Nicolazzi, Marie Garinot, Nathalie Mignet, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 7, 2012
Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumoursJohanne Seguin, Céline Nicolazzi, Nathalie Mignet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2003
Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation timeCéline Nicolazzi, Nathalie Mignet, Natalia de la Figuera, et al.
Journal of Clinical Pharmacology|February 1, 2017
Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug ConjugatesMarion Bouillon-Pichault, Claire Brillac, Céline Amara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicinDenis Ravel, Vincent Dubois, Jérôme Quinonero, et al.
Molecular Cancer Therapeutics|May 27, 2020
An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor ActivitiesCéline Nicolazzi, Anne Caron, Alexia Tellier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studiesFlorence Meyer-Losic, Céline Nicolazzi, Jérôme Quinonero, et al.
Nature Biotechnology|January 12, 2023
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123Laurent Gauthier, Angela Virone-Oddos, Jochen Beninga, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Antiviral Research|June 14, 2002
In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strainsCéline Nicolazzi, Véronique Venard, Alain Le Faou, et al.
The Journal of Gene Medicine|February 24, 2004
Physicochemical optimisation of plasmid delivery by cationic lipidsIsabelle Tranchant, Betty Thompson, Céline Nicolazzi, et al.
Current Medicinal Chemistry|April 8, 2003
Cationic lipids for transfectionCéline Nicolazzi, Marie Garinot, Nathalie Mignet, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 7, 2012
Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumoursJohanne Seguin, Céline Nicolazzi, Nathalie Mignet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2003
Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation timeCéline Nicolazzi, Nathalie Mignet, Natalia de la Figuera, et al.
Journal of Clinical Pharmacology|February 1, 2017
Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug ConjugatesMarion Bouillon-Pichault, Claire Brillac, Céline Amara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicinDenis Ravel, Vincent Dubois, Jérôme Quinonero, et al.
Molecular Cancer Therapeutics|May 27, 2020
An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor ActivitiesCéline Nicolazzi, Anne Caron, Alexia Tellier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studiesFlorence Meyer-Losic, Céline Nicolazzi, Jérôme Quinonero, et al.
Nature Biotechnology|January 12, 2023
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123Laurent Gauthier, Angela Virone-Oddos, Jochen Beninga, et al.
Pageof 2